Sanofi
About Us
About Us
Sanofi India Leadership Team
Making in India
Chasing the Miracles of Science
Chasing the Miracles of Science
Solutions in Diabetes
Transforming lives with transplantation
Fighting rare diseases
Protecting with vaccines
Our Science
Our Science
Pharmaceutical products
Vaccines
Specialty Care Products
For healthcare professionals
Sustainability
Sustainability
Access to health
Engaged communities
Environmental impact
Ethics & Business Integrity
Clinical Research Studies
Consumer Healthcare
Consumer Healthcare
Supporting good health & well-being – Sanofi India
Consumer Healthcare Products
Consumer Healthcare Products
All Products
Dulcoflex® - Constipation Relief Brand
For healthcare professionals
Investors
Investors
Our Business
Board of Directors and Leadership Team
Financial Results
Annual Reports
AGM
Investor Information
Disclosures Under Reg-46 of the Listing Regulations
CSR
Shareholder Corner
Scheme of Arrangement
Media
Media
Media Release
Drugs (Price Control) Order Matters
Media
Media
Press Releases
Company statements
Investors
Investors
Board of Directors and Leadership Team
Board of Directors and Leadership Team
Board of Directors
Directorships and full-time positions
Board Committees
Sanofi India Limited Leadership Team
Financial Results
Annual Reports
AGM
Scheme of Arrangement
Investor Information
Investor Information
Shareholding pattern
Corporate Governance
Analyst / Investor Meet
Postal Ballot
Secretarial Compliance Report
Related Party Disclosures
Annual Return
Stock Exchange Announcement and Disclosures
Newspaper Advertisement
Disclosures Under Reg. 46 of the Listing Regulations
Disclosures Under Reg. 46 of the Listing Regulations
Our Business
Letter of Appointment of Independent Directors
Composition of Board Committee
Code of Conduct and Policies
Familiarization Programme
Contact information for grievance redressal
Notice of Board Meeting
Financial results
Annual Reports
Shareholding Pattern
Analyst Meet
Notice given to shareholders by way advertisement
Audited Financial Results of Subsidiary
Secretarial Compliance Report
Policy for Determination of Materiality
KMP authorized for Determination of Materiality
Disclosures under Reg. 30 of the Listing Regulations
Memorandum and Articles of Association
Annual Return
CSR
Shareholder’s Corner
Shareholder’s Corner
Unclaimed Dividends
Unpaid Dividends
Unclaimed shares
Investor services
Contact Us
Careers
Contact Us
Chasing Miracles
Global
India
Drugs (Price Control) Order Matters
Drugs (Price Control) Order Matters
This page contains the details of the revised price notifications and Market Retail Prices as mandated by NPPA
S.O 5690 dt 17-10-2026 : TMR notification for 137 anti-cancer drugs
Annexure I Submission for revised prices
Form V copy for revised prices
Copy of communication to distributors
